Arrowhead Pharmaceuticals, Inc.

STIFEL FINANCIAL CORP ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

11,811

Value ($000)

784

Weight

0.0%

2019 Q4 - 2025 Q4 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	784	0.0%	11,811	12/31/2025
2022 Q4	2/13/2023	804	0.0%	19,821	12/31/2022
2022 Q3	11/14/2022	703	0.0%	21,273	9/30/2022
2022 Q2	8/15/2022	760	0.0%	21,579	6/30/2022
2022 Q1	5/13/2022	1,008	0.0%	21,917	3/31/2022
2021 Q4	2/14/2022	1,506	0.0%	22,708	12/31/2021
2021 Q3	11/15/2021	1,427	0.0%	22,853	9/30/2021
2021 Q2	8/13/2021	1,900	0.0%	22,936	6/30/2021
2021 Q1	5/14/2021	1,496	0.0%	22,560	3/31/2021
2020 Q4	2/12/2021	1,717	0.0%	22,383	12/31/2020
2020 Q3	11/16/2020	967	0.0%	22,466	9/30/2020
2020 Q2	8/14/2020	937	0.0%	21,701	6/30/2020
2020 Q1	5/14/2020	675	0.0%	23,413	3/31/2020
2019 Q4	2/13/2020	1,519	0.0%	23,975	12/31/2019